Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,323 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mucosal Immune System Dysregulation in the Pathogenesis of IgA Nephropathy.
Kano T, Suzuki H, Makita Y, Nihei Y, Fukao Y, Nakayama M, Lee M, Kato R, Aoki R, Yamada K, Muto M, Suzuki Y. Kano T, et al. Among authors: kato r. Biomedicines. 2022 Nov 24;10(12):3027. doi: 10.3390/biomedicines10123027. Biomedicines. 2022. PMID: 36551783 Free PMC article. Review.
Galactose-Deficient IgA1 as a Candidate Urinary Marker of IgA Nephropathy.
Fukao Y, Suzuki H, Kim JS, Jeong KH, Makita Y, Kano T, Nihei Y, Nakayama M, Lee M, Kato R, Chang JM, Lee SH, Suzuki Y. Fukao Y, et al. Among authors: kato r. J Clin Med. 2022 Jun 2;11(11):3173. doi: 10.3390/jcm11113173. J Clin Med. 2022. PMID: 35683557 Free PMC article.
Comparison between Long- and Short-Acting Erythropoiesis-Stimulating Agents in the Period Required for Haemoglobin Stabilisation in Treatment of Anaemia in Patients with Chronic Kidney Disease.
Hayashi T, Nagamatsu T, Matsushita A, Mizuno T, Nishibe S, Noguchi A, Kato R, Toda T, Tanaka J, Takahashi H, Hayashi H, Yuzawa Y, Yamada S. Hayashi T, et al. Among authors: kato r. Biol Pharm Bull. 2015;38(5):740-5. doi: 10.1248/bpb.b14-00844. Epub 2015 Feb 25. Biol Pharm Bull. 2015. PMID: 25740003 Free article.
An Aspirin-Free Strategy for Immediate Treatment Following Complex Percutaneous Coronary Intervention.
Yamamoto K, Natsuaki M, Watanabe H, Morimoto T, Obayashi Y, Nishikawa R, Ando K, Suwa S, Isawa T, Takenaka H, Ishikawa T, Tamura T, Kawahatsu K, Hayashi F, Akao M, Serikawa T, Mori H, Kawamura T, Hagikura A, Shibata N, Ono K, Kimura T; STOPDAPT-3 Investigators. Yamamoto K, et al. JACC Cardiovasc Interv. 2024 May 13;17(9):1119-1130. doi: 10.1016/j.jcin.2024.03.017. JACC Cardiovasc Interv. 2024. PMID: 38749592
Pre-first-line chemotherapy risk stratification for overall survival in advanced urothelial carcinoma in sequential therapy era.
Shindo T, Hashimoto K, Fujino K, Takahashi A, Hotta H, Maeda T, Kunishima Y, Fukuta F, Ito N, Wanifuchi A, Kato R, Okada M, Matsukawa M, Horita H, Takayanagi A, Kobayashi K, Tanaka T, Masumori N. Shindo T, et al. Among authors: kato r. World J Urol. 2024 May 9;42(1):307. doi: 10.1007/s00345-024-04952-z. World J Urol. 2024. PMID: 38722418
2,323 results